DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Neoptolemos J, Buechler M, Stocken D. et al.
ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. In: 2009 ASCO Annual Meeting.
J Clin Oncol 2009; 27: Abstract LBA4505-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.